Related references
Note: Only part of the references are listed.Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea
Sung Min Baek et al.
GUT AND LIVER (2020)
Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations
Muhammad Miftahussurur et al.
PLOS ONE (2020)
Prevalence of atrophic gastritis in southwest China and predictive strength of serum gastrin-17: A cross-sectional study (SIGES)
Rui Wang et al.
SCIENTIFIC REPORTS (2020)
Is serum pepsinogen testing necessary in population-based screening for gastric cancer?
Yeon-Ji Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2020)
A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area
Nicolas Chapelle et al.
HELICOBACTER (2020)
Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area
Boldbaatar Gantuya et al.
GASTRIC CANCER (2019)
Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study
Quancai Cai et al.
GUT (2019)
Initial Trials With Susceptibility-Based and Empiric Anti-H. pylori Therapies in Mongolia
Tsogt-Ochir Byambajav et al.
FRONTIERS IN PHARMACOLOGY (2019)
A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study
Huakang Tu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer
Takeichi Yoshida et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Pepsinogen II Can Be a Potential Surrogate Marker of Morphological Changes in Corpus before and after H-pylori Eradication
Sadegh Massarrat et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Screening for Gastric Cancer: The Usefulness of Endoscopy
Kui Son Choi et al.
CLINICAL ENDOSCOPY (2014)
Sensitivity of endoscopic screening for gastric cancer by the incidence method
Chisato Hamashima et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
A Community-Based, Case-Control Study Evaluating Mortality Reduction from Gastric Cancer by Endoscopic Screening in Japan
Chisato Hamashima et al.
PLOS ONE (2013)
Serological assessment of gastric mucosal atrophy in gastric cancer
Jan Bornschein et al.
BMC GASTROENTEROLOGY (2012)
The gastric precancerous cascade
Pelayo Correa et al.
JOURNAL OF DIGESTIVE DISEASES (2012)
Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-ABC method
Kazumasa Miki
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2011)
Low Levels of Pepsinogen I and Pepsinogen I/II Ratio are Valuable Serologic Markers for Predicting Extensive Gastric Corpus Atrophy in Patients Undergoing Endoscopic Mucosectomy
Ho June Song et al.
GUT AND LIVER (2010)
The Role of Serum Pepsinogen in the Detection of Gastric Cancer
Nayoung Kim et al.
GUT AND LIVER (2010)
Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea
Hyun Young Kim et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Validation of the pepsinogen test method for gastric cancer screening using a follow-up study
Shigeto Mizuno et al.
GASTRIC CANCER (2009)
The Production and Role of Gastrin-17 and Gastrin-17-Gly in Gastrointestinal Cancers
Jeffrey Copps et al.
PROTEIN AND PEPTIDE LETTERS (2009)
The role of serum pepsinogen and gastrin test for the detection of gastric cancer in korea
Jung Mook Kang et al.
HELICOBACTER (2008)
Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies
Qin Cao et al.
JOURNAL OF DIGESTIVE DISEASES (2007)
Share Paper
